Merck plans large Phase III outpatient trial of molnupiravir in Covid-19

The study will include patients with Covid-19 who have at least one risk factor for poor outcomes, such as advanced age, obesity or diabetes. There were some encouraging signals in a prior outpatient study, but its development for hospitalised patients will be discontinued.

Reuters Health